The excipients market is witnessing steady expansion as pharmaceutical companies increasingly prioritize advanced formulation technologies, enhanced drug delivery systems, and improved therapeutic performance. The global excipients market size was estimated at USD 10,690.68 million in 2025 and is projected to reach USD 14,746.68 million by 2033, growing at a CAGR of 4.11% from 2026 to 2033. Excipients are no longer considered inactive ingredients alone; they have become essential components in modern pharmaceutical development due to their ability to improve drug stability, solubility, bioavailability, and patient compliance. Pharmaceutical manufacturers are increasingly adopting multifunctional excipients to gain formulation efficiency and create differentiated products in highly competitive therapeutic markets. The growing complexity of drug molecules and increasing demand for controlled-release formulations are further strengthening the role of excipients across oral, topical, and advanced delivery systems.
Continuous research and development activities focused on optimized excipients for enhanced drug delivery are significantly contributing to market growth. Pharmaceutical companies are investing in advanced excipient technologies that support targeted delivery, extended-release mechanisms, and higher formulation consistency. The rising adoption of biologics, complex generics, and specialty drugs is also accelerating the demand for innovative excipient solutions. In addition, regulatory emphasis on product quality, safety, and formulation performance is encouraging manufacturers to develop high-purity and multifunctional pharmaceutical ingredients. The market is also benefiting from increasing interest in sustainable and plant-based excipients, particularly among companies aiming to align with evolving environmental and healthcare preferences. As the pharmaceutical sector continues to evolve toward patient-centric therapies and precision medicine, excipients are becoming increasingly critical in improving manufacturing scalability, therapeutic effectiveness, and overall drug performance.
Key Market Trends & Insights
· Europe excipients market held the largest share of 37.21% of the global market in 2025, reflecting the region’s strong pharmaceutical manufacturing ecosystem, advanced research infrastructure, and growing investment in drug formulation technologies. The excipients industry in the U.K. is expected to grow significantly over the forecast period due to increasing pharmaceutical innovation, rising demand for advanced drug delivery systems, and strong regulatory support for high-quality pharmaceutical ingredients.
· By product, polymers held the highest market share of 45.66% in 2025. Polymer-based excipients are widely utilized because of their superior functionality in controlled-release systems, tablet formulation, coating applications, and solubility enhancement. Their versatility in improving stability and drug release profiles continues to drive demand across pharmaceutical manufacturing.
· By function, binders held the highest market share of 13.08% in 2025. Binders play a critical role in maintaining tablet integrity, improving compressibility, and supporting efficient manufacturing processes. The increasing production of oral solid dosage forms is expected to sustain strong demand for binder excipients over the coming years.
· By formulation, the oral formulation segment held the highest market share of 55.66% in 2025. Oral dosage forms remain the most preferred drug delivery route due to ease of administration, patient convenience, cost-effectiveness, and high acceptance across therapeutic categories. This trend continues to support extensive usage of excipients in tablet, capsule, and liquid oral formulations.
Looking for more specific insights? Customize this report to suite your business needs
Key Companies & Market Share Insights
Leading companies are actively contributing to technological advancements and formulation innovation within the excipients industry. Eastman Chemical Company, P&G Chemicals, and Avantor Performance Materials, LLC are strengthening the market through continuous innovation in functional ingredients that enhance drug stability, solubility, and bioavailability. Huntsman Corporation and BASF SE are expanding their pharmaceutical excipient portfolios by investing in high-performance materials and advanced formulation technologies designed for complex drug delivery systems.
Meanwhile, Ashland Inc. and Lubrizol Corporation are focusing on polymer-based excipients and controlled-release solutions that support next-generation oral and topical dosage forms. FMC Corporation continues to enhance formulation efficiency and product consistency through specialty chemistry expertise. Roquette is expanding its plant-based excipient portfolio to address rising demand for natural and sustainable pharmaceutical ingredients, while Colorcon Inc. remains a major contributor in film coatings and modified-release technologies that improve drug performance and patient adherence. Collectively, these companies are shaping the future of pharmaceutical formulation through innovation, scalability, and regulatory-focused excipient development.
Key Excipients Companies:
· Eastman Chemical Corporation
· P&G Chemicals
· Avantor Performance Materials, LLC
· Huntsman Corporation
· BASF SE
· Ashland Inc.
· FMC Corporation
· Roquette
· Colorcon Inc.
· Lubrizol Corporation
Grand View Research offers
· Focused market intelligence reports on specific geographies or high-growth segments.
· Extended forecast timelines for long-term planning.
· Competitor Benchmarking and Supply Chain Analysis
· Inclusion of regulatory and policy assessments.
· Inclusion of custom data models, KPIs, or applications unique to your business
· Specific high-impact Data Decks and Tables to support effective decision making
· And much more…
Looking for a report customized to your requirements? Explore our Custom Research Offering
Comments